Breaking News
October 24, 2018 - Radiotherapy combined with androgen-deprivation therapy improves overall survival up to 10 years
October 24, 2018 - Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
October 24, 2018 - Researcher uses smartphone to detect breast cancer gene
October 24, 2018 - Advanced breast cancer patients can benefit from immunotherapy-chemotherapy combination
October 24, 2018 - Stress related to social stigma negatively impacts mental health of autistic people
October 24, 2018 - New 17-item questionnaire may help detect GI disorders in children with autism
October 24, 2018 - 12% of frequent marijuana smokers experience cannabis withdrawal syndrome
October 24, 2018 - Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis
October 24, 2018 - Poor Experience With PCP Linked to Hospitalization in CKD
October 23, 2018 - Dummies not to blame for common speech disorder in kids
October 23, 2018 - The future of ethics and biomedicine: An interview
October 23, 2018 - X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma
October 23, 2018 - FDA targets 465 websites that sell potentially dangerous, unapproved drugs
October 23, 2018 - New approach may lead to better diagnostic techniques for autoimmune disorders
October 23, 2018 - Innovative computer software sheds new light on genetic processes underlying deadly diseases
October 23, 2018 - Juul Drawing Lots of Teen Followers on Twitter
October 23, 2018 - WHO says Zika risk low in Pacific ahead of Meghan visit
October 23, 2018 - A deeper look at ‘Reflecting Frankenstein’
October 23, 2018 - Breastfeeding can have protective affect against high blood pressure in women, confirms study
October 23, 2018 - Epigenetic modifications may contribute to Alzheimer’s Disease
October 23, 2018 - Volunteering for peer counseling programs benefits people with lupus
October 23, 2018 - Cancer treatment may undergo a paradigm shift to immunotherapy soon
October 23, 2018 - Study uncovers new mechanism of action in a first-line drug for diabetes
October 23, 2018 - New type of molecule shows early promise against treatment-resistant prostate cancer
October 23, 2018 - Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients
October 23, 2018 - Scientists grow functioning human neural networks in 3D from stem cells
October 23, 2018 - Using mushrooms as a prebiotic may help improve glucose regulation
October 23, 2018 - New ENT clinic treats children in Zimbabwe
October 23, 2018 - CUIMC Celebrates 2018-2019, Issue 2
October 23, 2018 - Immunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer
October 23, 2018 - Intake of painkillers during pregnancy linked to early puberty in future offspring
October 23, 2018 - ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use
October 23, 2018 - Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage
October 23, 2018 - Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics
October 23, 2018 - Lowering systolic blood pressure does not damage the kidneys, shows study
October 23, 2018 - Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
October 23, 2018 - Cardiovascular admissions more common among most deprived
October 23, 2018 - Targeted drug and hormone therapy combination extends breast cancer survival
October 23, 2018 - Map of human liver cells reveals molecular make-up of individual cells
October 23, 2018 - Drugs approved for breast cancer treatment are effective and well tolerated in men
October 23, 2018 - EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring
October 23, 2018 - Researchers identify common genetic connection in lung conditions
October 23, 2018 - Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC
October 23, 2018 - Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer
October 23, 2018 - New discovery may lead to better treatment options for pancreatic cancer patients
October 23, 2018 - FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma
October 23, 2018 - Researchers identify immune culprits linked to inflammation and bone loss in gum disease
October 23, 2018 - Despite lower risk factors, black men have higher rates of recidivism
October 23, 2018 - Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery
October 23, 2018 - AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis
October 23, 2018 - NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
October 23, 2018 - Scientists use electron microscope to study chemical transformation in catalytic cross-coupling reaction
October 23, 2018 - Research offers new hope to men who received childhood cancer treatment
October 23, 2018 - New medical navigation system receives international innovation award
October 23, 2018 - Adverse Childhood Experiences Tied to Burnout in BSN Students
October 23, 2018 - High levels of oral disease among elite athletes affecting performance
October 23, 2018 - Study examines effect of immediate vs delayed pushing during labor on delivery outcomes
October 23, 2018 - LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations
October 23, 2018 - Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients
October 23, 2018 - Organic food may protect against cancers finds study
October 23, 2018 - Interweaving anxiety disorder associated with stuttering remains unrecognized
October 23, 2018 - Cannabis oil shown to significantly improve Crohn’s disease symptoms
October 23, 2018 - Knowledge of sex differences in lower urinary tract may help stimulate breakthroughs in diagnosis, management
October 23, 2018 - Common antibodies associated with myocardial infarction
October 23, 2018 - Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy
October 23, 2018 - Brain’s ‘Self-Control’ Center May Be Key to Weight-Loss Success
October 23, 2018 - Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death
October 23, 2018 - Can virtual reality help people become more compassionate?
October 23, 2018 - Screen time eclipsed outdoor time for most students, shows study
October 23, 2018 - SLU researcher seeks to find solutions for ‘chemo brain’ symptoms and side effects of opioids
October 23, 2018 - Plastics now commonly found in human stools
October 23, 2018 - Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
FDA looks to remove nicotine from cigarettes

FDA looks to remove nicotine from cigarettes

image_pdfDownload PDFimage_print

Smoking kills thousands each year and in a bid to reduce the impact of smoking the Food and Drug Administration (FDA) announced a tobacco regulation plan. This new plan is essentially simple – it aims to reduce the nicotine content of the cigarettes to such a level that they cease to be addictive any more.

Image Credit: DANAI KHAMPIRANON / Shutterstock

Image Credit: DANAI KHAMPIRANON / Shutterstock

Smoking is the cause of lung cancer in more than 90% of cases and is the single biggest risk factor for lung cancer. There are more than 60 different toxins in tobacco smoke that can cause cancer. Although tobacco smoking is the main risk factor for lung cancer, other tobacco products such as pipe tobacco, cigars, chewing tobacco and snuff can also raise the risk of lung cancer and other forms of cancer such as mouth cancer and esophageal cancer.

According to FDA Commissioner Scott Gottlieb, very soon cigarettes may contain up to 0.4 milligrams of nicotine per gram of tobacco. This would be a 97 percent reduction from the conventional cigarettes sold today. Gottlieb says that this reduction would result in 5 million individuals quitting smoking in a year. Smoking rates at present are 15 percent and with this regulation implementation, it is expected to come down to 1.4 percent.  By end of this century, this measure alone would have saved 8 million lives he explained calling this “an undeniable public health benefit.” These numbers are obtained from a research by the FDA and researchers from Sandia National Laboratories in Albuquerque, published in the latest issue of the New England Journal of Medicine (15th March 2018).

The announcement yesterday is an advance notice of the regulation plan at present. Gottlieb has called for a public consensus and debate on the ideal nicotine levels in the tobacco that is used in cigarettes. He raised concerns regarding black markets that could arise with high-nicotine cigarettes. He explained that there were also concerns regarding smokers increasing their number of cigarettes to get the “kick” rather than quitting with the low-nicotine cigarettes. “It’s critical that our policies reflect the latest science and is informed by the input we receive,” he said. He called upon experts and public to debate over these issues. Comments are invited over the next 90 days. The rules may come into the picture somewhere around mid-June.

James Figlar, executive vice president of research and development for R.J. Reynolds Tobacco Co., from the other end said that they would work alongside FDA to appreciate the continuum of risk as well as “tobacco harm reduction”. According to experts low-nicotine cigarettes like Marlboro UItra Lights containing 0.5 milligrams of nicotine per cigarette have been on the markets for years and they are less popular. Further Michael Russell in 1976 in his pioneering research work had found that people die of the diseases caused by the “tar” in the cigarettes rather than the nicotine. Further electronic cigarettes have been found to deliver much less nicotine and toxic chemicals than traditional cigarettes. It is not clear now how low-nicotine cigarettes would fare compared to the e-cigarettes and the impact they would have.

However there are several studies that show that reducing the nicotine amounts in the cigarettes can reduce the number of cigarettes smoked daily. Many of the participants in these exercises were found to be quitting at the end of the trial.

Mitch Zeller, director of the FDA’s Center for Tobacco Products, along with Gottlieb said that they would be launching two other regulatory initiatives related to tobacco soon. These would be regarding the menthol and flavoring agent content of the cigarettes and contents of premium cigars respectively.

Posted in: Men’s Health News | Women’s Health News

Tags: Cancer, Cigarette, Esophageal Cancer, Lung Cancer, Mouth Cancer, Nicotine, Public Health, Research, Smoking, Tobacco, Toxins

Tagged with:

About author

Related Articles